Stockreport

2seventy bio Reports Fourth Quarter and Full Year 2024 Financial Results

2seventy bio, Inc.  (TSVT) 
PDF Entered into definitive merger agreement to be acquired by Bristol Myers Squibb at a price of $5.00 per share in an all-cash transaction; expected to close in the second [Read more]